(4-ALKOXYPYRAN-4-YL) SUBSTITUTED ARYLALKYLARYL-, ARYLALKENYLARYL-, AND ARYLALKYNYLARYLUREA INHIBITORS OF 5-LIPOXYGENASE
    1.
    发明申请
    (4-ALKOXYPYRAN-4-YL) SUBSTITUTED ARYLALKYLARYL-, ARYLALKENYLARYL-, AND ARYLALKYNYLARYLUREA INHIBITORS OF 5-LIPOXYGENASE 审中-公开
    (4-ALKOXYPYRAN-4-YL)取代的芳基乙烯基-L-亚苄基胆碱酯酶和5-氯吡咯烷酮的芳基烯丙基胺抑制剂

    公开(公告)号:WO1994026264A1

    公开(公告)日:1994-11-24

    申请号:PCT/US1994005341

    申请日:1994-05-12

    CPC classification number: C07D405/12 C07D309/12

    Abstract: Compounds of structure (I), wherein W is selected from (a), and (b), where Q is oxygen or sulfur, R and R are hydrogen or alkyl, or R and R , together with the nitrogen atoms to which they are attached, define a radical of formula (II) or (III), R is selected from hydrogen, alkyl, haloalkyl, optionally substituted phenyl, hydroxyalkyl, aminoalkyl, carboxyalkyl, (alkoxycarbonyl)alkyl, and (alkylaminocarbonyl)alkyl; Z is -CH2-, oxygen, sulfur, or -NR where R is hydrogen or alkyl, L and L are selected from a valence bond, alkylene, propenylene, and propynylene, R , R , R , and R are independently selected from alkyl, haloalkyl, halogen, cyano, amino, alkoxycarbonyl, and dialkylaminocarbonyl, Y is selected from oxygen, -NR , where R is hydrogen or alkyl, and (c), where n = 0, 1, or 2, and R is alkyl, inhibit the biosynthesis of leukotrienes. These compounds are useful in the treatment or amelioration of allergic and inflammatory disease states.

    Abstract translation: 其中W选自(a)和(b)中的结构(I)的化合物,其中Q是氧或硫,R 6和R 7是氢或烷基,或R 6和R 6, (II)或(III)的基团,其中R 8与它们所连接的氮原子一起定义为式(II)或(III)的基团,R 8选自氢,烷基,卤代烷基,任选取代的苯基,羟基烷基,氨基烷基,羧基烷基, (烷氧基羰基)烷基和(烷基氨基羰基)烷基; Z是-CH 2 - ,氧,硫或-NR 9,其中R 9是氢或烷基,L 1和L 2选自价键,亚烷基,亚丙烯基和亚丙炔基,R R 1,R 2,R 3和R 4独立地选自烷基,卤代烷基,卤素,氰基,氨基,烷氧基羰基和二烷基氨基羰基,Y选自氧,-NR 10, 其中R 10是氢或烷基,和(c)其中n = 0,1或2,R 5是烷基,抑制白细胞三烯的生物合成。 这些化合物可用于治疗或改善过敏性和炎性疾病状态。

Patent Agency Ranking